Ziegler S, Kim J, Ehmsen J, Vernon H
Dis Model Mech. 2023; 16(11).
PMID: 37994477
PMC: 10690057.
DOI: 10.1242/dmm.050233.
Winn S, Dudley S, Scherer T, Rimann N, Thony B, Boutros S
Mol Genet Metab. 2022; 136(1):46-64.
PMID: 35339387
PMC: 9106909.
DOI: 10.1016/j.ymgme.2022.03.008.
Borges A, Broersen K, Leandro P, Fernandes T
Front Mol Neurosci. 2022; 14:787242.
PMID: 35082602
PMC: 8784555.
DOI: 10.3389/fnmol.2021.787242.
Ahring K, Dagnaes-Hansen F, Bruel A, Christensen M, Jensen E, Jensen T
PLoS One. 2022; 17(1):e0261150.
PMID: 35015767
PMC: 8751992.
DOI: 10.1371/journal.pone.0261150.
van Spronsen F, Blau N, Harding C, Burlina A, Longo N, Bosch A
Nat Rev Dis Primers. 2021; 7(1):36.
PMID: 34017006
PMC: 8591558.
DOI: 10.1038/s41572-021-00267-0.
P-cresol Alters Brain Dopamine Metabolism and Exacerbates Autism-Like Behaviors in the BTBR Mouse.
Pascucci T, Colamartino M, Fiori E, Sacco R, Coviello A, Ventura R
Brain Sci. 2020; 10(4).
PMID: 32294927
PMC: 7226382.
DOI: 10.3390/brainsci10040233.
Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments.
Ashe K, Kelso W, Farrand S, Panetta J, Fazio T, de Jong G
Front Psychiatry. 2019; 10:561.
PMID: 31551819
PMC: 6748028.
DOI: 10.3389/fpsyt.2019.00561.
Inhibiting neutral amino acid transport for the treatment of phenylketonuria.
Belanger A, Przybylska M, Gefteas E, Furgerson M, Geller S, Kloss A
JCI Insight. 2018; 3(14).
PMID: 30046012
PMC: 6124451.
DOI: 10.1172/jci.insight.121762.
Targeting mGlu5 Metabotropic Glutamate Receptors in the Treatment of Cognitive Dysfunction in a Mouse Model of Phenylketonuria.
Nardecchia F, Orlando R, Iacovelli L, Colamartino M, Fiori E, Leuzzi V
Front Neurosci. 2018; 12:154.
PMID: 29615849
PMC: 5864888.
DOI: 10.3389/fnins.2018.00154.
Tetrahydrobiopterin treatment reduces brain L-Phe but only partially improves serotonin in hyperphenylalaninemic ENU1/2 mice.
Scherer T, Allegri G, Sarkissian C, Ying M, Grisch-Chan H, Rassi A
J Inherit Metab Dis. 2018; 41(4):709-718.
PMID: 29520738
PMC: 6041158.
DOI: 10.1007/s10545-018-0150-y.
Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.
Winn S, Scherer T, Thony B, Ying M, Martinez A, Weber S
Mol Genet Metab. 2018; 123(1):6-20.
PMID: 29331172
PMC: 5786171.
DOI: 10.1016/j.ymgme.2017.10.009.
Early-onset behavioral and neurochemical deficits in the genetic mouse model of phenylketonuria.
Fiori E, Oddi D, Ventura R, Colamartino M, Valzania A, DAmato F
PLoS One. 2017; 12(8):e0183430.
PMID: 28850618
PMC: 5574541.
DOI: 10.1371/journal.pone.0183430.
Unbalance between Excitation and Inhibition in Phenylketonuria, a Genetic Metabolic Disease Associated with Autism.
De Jaco A, Mango D, De Angelis F, Favaloro F, Andolina D, Nistico R
Int J Mol Sci. 2017; 18(5).
PMID: 28468253
PMC: 5454854.
DOI: 10.3390/ijms18050941.
The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
Romani C, Palermo L, MacDonald A, Limback E, Hall S, Geberhiwot T
Neuropsychology. 2017; 31(3):242-254.
PMID: 28240926
PMC: 5331922.
DOI: 10.1037/neu0000336.
The Behavioral Consequence of Phenylketonuria in Mice Depends on the Genetic Background.
Bruinenberg V, van der Goot E, van Vliet D, de Groot M, Mazzola P, Heiner-Fokkema M
Front Behav Neurosci. 2017; 10:233.
PMID: 28066199
PMC: 5167755.
DOI: 10.3389/fnbeh.2016.00233.
Role of prefrontal 5-HT in the strain-dependent variation in sign-tracking behavior of C57BL/6 and DBA/2 mice.
Campus P, Accoto A, Maiolati M, Latagliata C, Orsini C
Psychopharmacology (Berl). 2016; 233(7):1157-69.
PMID: 26728892
DOI: 10.1007/s00213-015-4192-7.
High dose sapropterin dihydrochloride therapy improves monoamine neurotransmitter turnover in murine phenylketonuria (PKU).
Winn S, Scherer T, Thony B, Harding C
Mol Genet Metab. 2015; 117(1):5-11.
PMID: 26653793
PMC: 4706464.
DOI: 10.1016/j.ymgme.2015.11.012.
Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.
Gessler D, Gao G
Methods Mol Biol. 2015; 1382:429-65.
PMID: 26611604
PMC: 4961359.
DOI: 10.1007/978-1-4939-3271-9_30.
Neurobehavioral Alterations in a Genetic Murine Model of Feingold Syndrome 2.
Fiori E, Babicola L, Andolina D, Coassin A, Pascucci T, Patella L
Behav Genet. 2015; 45(5):547-59.
PMID: 26026879
PMC: 4561592.
DOI: 10.1007/s10519-015-9724-8.
When chocolate seeking becomes compulsion: gene-environment interplay.
Patrono E, Di Segni M, Patella L, Andolina D, Valzania A, Latagliata E
PLoS One. 2015; 10(3):e0120191.
PMID: 25781028
PMC: 4363151.
DOI: 10.1371/journal.pone.0120191.